🇺🇸 FDA
Pipeline program

SHJ002/Vehicle

SHJ002-DED2203

Phase 2 small_molecule completed

Quick answer

SHJ002/Vehicle for Dry Eye Disease is a Phase 2 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Dry Eye Disease
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials